Related Experiment Video
Updated: Aug 3, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
Published on: February 21, 2020
Closure procedures for monotone bi-factorial dose-response designs
1Institute of Medical Statistics, Informatics, and Epidemiology, University of Cologne, D-50924 Cologne, Germany. martin.hellmich@medizin.uni-koeln.de
Abstract:
Two goals of multiple-dose factorial trials are (i) demonstrating improved effectiveness of a fixed combination over each of its components as well as (ii) identifying a safe and effective dose range. The authors address both goals though with focus on the second by closure procedures that guarantee strong control of the familywise error rate. Two different families of null hypotheses are investigated for bi-factorial dose-response designs that are monotone with respect to the matrix partial order. One is suitable to find the minimum effective dose(s) and the other one is large enough to identify the highest effective dose step(s). Likelihood ratio tests and appropriate multiple contrast tests are applied to an unbalanced clinical trial example taken from Hung (2000, Statistics in Medicine 19, 2079-2087). Full computer code written in the R language is available from the Internet.
Insights
This study introduces methods for multiple-dose factorial trials to identify optimal drug dosages. It focuses on finding safe and effective dose ranges while ensuring strong control of statistical error rates.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Pharmacometrics
Background:
- Multiple-dose factorial trials aim to prove combination therapy effectiveness and determine optimal dose ranges.
- Establishing safe and effective dose ranges is crucial for drug development.
- Statistical methods are needed to control error rates in complex trial designs.
Purpose of the Study:
- To present closure procedures for bi-factorial dose-response designs that guarantee strong control of the familywise error rate.
- To investigate two families of null hypotheses for identifying minimum and maximum effective doses.
- To demonstrate the application of these methods in an unbalanced clinical trial.
Main Methods:
- Utilizing closure procedures to ensure strong control of the familywise error rate.
- Applying likelihood ratio tests and multiple contrast tests.
- Investigating bi-factorial dose-response designs with monotone properties.
Main Results:
- The proposed methods effectively address the dual goals of demonstrating combination effectiveness and identifying dose ranges.
- Two distinct families of null hypotheses allow for the identification of minimum and maximum effective doses.
- The methods were successfully applied to a real-world unbalanced clinical trial example.
Conclusions:
- The developed statistical procedures provide a robust framework for dose-finding in factorial trials.
- These methods enhance the precision and reliability of identifying optimal therapeutic doses.
- The availability of R code facilitates the practical implementation of these advanced statistical techniques.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Dosage Regimens: Designs and Approaches
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Dose Response Curve: Conventional Versus Nonmonotonic